🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Start Date
2006-10
Trial ID
NCT00433433
Treatments Being Tested
Combined modality therapy has then emerged as the standard of care for limi...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-09
Trial ID
NCT00992030
Treatments Being Tested
This study enrolls newly diagnosed unfavorable stage II /stage III-IV class...
Status
Completed
Location
Peking University People's Hospital
Start Date
2019-02-01
Trial ID
NCT07720011
Treatments Being Tested
This trial proposes a therapy for pediatric Hodgkin lymphoma with the objec...
Status
Recruiting
Location
Hospital JP Garrahan
Start Date
2017-10-06
Trial ID
NCT03500133
Treatments Being Tested
This is an observational, multicenter, prospective cohort study including p...
Status
Not Yet Recruiting
Location
Clinica di Ematologia, AOU Ospedali Riuniti
Start Date
2026-09
Trial ID
NCT07652476
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Long Beach Memorial Medical Center
Start Date
1999-10
Trial ID
NCT00004010
This phase II trial studies how well brentuximab vedotin and nivolumab work...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-11-28
Trial ID
NCT03712202
This study will examine the safety and efficacy of pembrolizumab (MK-3475) ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama ( Site 0023)
Start Date
2018-04-09
Trial ID
NCT03407144